BIORCHESTRA Announces 45 Million USD Series C Fundraising
Back to list BIORCHESTRA Announces 45 Million USD Series C Fundraising BIORCHESTRA is a leading RNA therapeutics company whose lead programs focus on neurodegenerative diseases using its proprietary RNA-based drug…